Pulmonx (LUNG) Shares Outstanding (2019 - 2025)

Pulmonx (LUNG) has 7 years of Shares Outstanding data on file, last reported at $41.7 million in Q4 2025.

• Quarterly Shares Outstanding rose 4.74% year-over-year to $41.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41.7 million (up 4.74% YoY) and the FY2025 annual result came in at $41.7 million, up 4.74% from the prior year.
• Shares Outstanding advanced to $41.7 million in Q4 2025 per LUNG's latest filing, from $41.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $41.7 million in Q4 2025 and bottomed at $35.8 million in Q1 2021.
• The 5-year median for Shares Outstanding is $38.2 million (2023), against an average of $38.5 million.
• The widest annual swing landed in 2021, when Shares Outstanding soared 1635.08%; it then advanced 1.6% in 2022.
• Tracing LUNG's Shares Outstanding over 5 years: stood at $36.9 million in 2021, then gained by 1.69% to $37.6 million in 2022, then increased by 2.56% to $38.5 million in 2023, then advanced by 3.3% to $39.8 million in 2024, then increased by 4.74% to $41.7 million in 2025.
• Per Business Quant, the three latest LUNG Shares Outstanding figures stand at $41.7 million (Q4 2025), $41.2 million (Q3 2025), and $40.7 million (Q2 2025).

Peer Comparison